Vascular Biogenics (NASDAQ:VBLT) Receives New Coverage from Analysts at StockNews.com

StockNews.com started coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a research note released on Tuesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Stock Down 7.5 % NASDAQ VBLT opened at $0.26 on Tuesday. The company has a market capitalization of $17.91 million, a price-to-earnings […]

Related Keywords

United States ,Israel , ,Advisor Group Holdings Inc ,Medicard Ltd ,Vascular Biogenics Company Profile ,Renaissance Technologies ,Envestnet Asset Management Inc ,Vascular Biogenics Ltd ,Vascular Biogenics ,Free Report ,Biogenics Stock Down ,Get Free Report ,Asset Management ,Sigma Investments ,Advisor Group Holdings ,Group Holdings ,Biogenics Ltd ,Vascular Biogenics Daily ,Nasdaq Vblt ,Vblt ,Medical ,Initiated Coverage ,Stocknews Com ,